Expertise in
8
conditions

Ting Sun

State Key Laboratory Of Experimental Hematology, Tianjin Key Laboratory Of Gene Therapy For Blood Diseases, CAMS Key Laboratory Of Gene Therapy For Blood Diseases, Chinese Academy Of Medical Sciences And Peking Union Medical College, 
Tianjin, CN 
Expertise in
8
conditions
State Key Laboratory Of Experimental Hematology, Tianjin Key Laboratory Of Gene Therapy For Blood Diseases, CAMS Key Laboratory Of Gene Therapy For Blood Diseases, Chinese Academy Of Medical Sciences And Peking Union Medical College, 
Tianjin, CN 
OverviewLocationsClinical Research

Overview

Ting Sun practices in Tianjin, China. Ms. Sun is highly rated in 8 conditions, according to our data. Her top areas of expertise are Blood Clots, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Purpura, and Splenectomy.

Her clinical research consists of co-authoring 32 peer reviewed articles. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

State Key Laboratory Of Experimental Hematology, Tianjin Key Laboratory Of Gene Therapy For Blood Diseases, CAMS Key Laboratory Of Gene Therapy For Blood Diseases, Chinese Academy Of Medical Sciences And Peking Union Medical College, Tianjin, 300020, China
Other Locations
State Key Laboratory Of Experimental Hematology, Tianjin Key Laboratory Of Gene Therapy For Blood Diseases, CAMS Key Laboratory Of Gene Therapy For Blood Diseases, Chinese Academy Of Medical Sciences & Peking Union Medical College, Tianjin 300020, Tianjin 301600, Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing, 100730, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

32 Total Publications

Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia.
Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia.
Journal: The New England journal of medicine
Published: May 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sun's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile